GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » ROC %

CardioGenics Holdings (CardioGenics Holdings) ROC % : -75.32% (As of Jan. 2016)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. CardioGenics Holdings's annualized return on capital (ROC %) for the quarter that ended in Jan. 2016 was -75.32%.

As of today (2024-06-08), CardioGenics Holdings's WACC % is 0.00%. CardioGenics Holdings's ROC % is 0.00% (calculated using TTM income statement data). CardioGenics Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.


CardioGenics Holdings ROC % Historical Data

The historical data trend for CardioGenics Holdings's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings ROC % Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,605.45 -430.38 -634.33 -144.94 -82.35

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -96.21 -78.83 -49.60 -121.99 -75.32

CardioGenics Holdings ROC % Calculation

CardioGenics Holdings's annualized Return on Capital (ROC %) for the fiscal year that ended in Oct. 2015 is calculated as:

ROC % (A: Oct. 2015 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Oct. 2014 ) + Invested Capital (A: Oct. 2015 ))/ count )
=-0.772 * ( 1 - 0% )/( (0.791 + 1.084)/ 2 )
=-0.772/0.9375
=-82.35 %

where

CardioGenics Holdings's annualized Return on Capital (ROC %) for the quarter that ended in Jan. 2016 is calculated as:

ROC % (Q: Jan. 2016 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2015 ) + Invested Capital (Q: Jan. 2016 ))/ count )
=-0.804 * ( 1 - 0% )/( (1.084 + 1.051)/ 2 )
=-0.804/1.0675
=-75.32 %

where

Note: The Operating Income data used here is four times the quarterly (Jan. 2016) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioGenics Holdings  (OTCPK:CGNH) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, CardioGenics Holdings's WACC % is 0.00%. CardioGenics Holdings's ROC % is 0.00% (calculated using TTM income statement data). CardioGenics Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


CardioGenics Holdings ROC % Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines